Page 156 - 2020_09-Haematologica-web

P.C.S. van Paridon et al.
parameters as independent biomarkers for increased mor- tality risk. The observed association of TG and traditional CVRF, particularly obesity, is an important finding in light of the growing “globesity’’ issue worldwide.31
Acknowledgments
We are indebted to all study participants and all co-workers of the Gutenberg Health Study, who were involved in the plan- ning and conduct of this study.
Funding
The Gutenberg Health Study is funded through the govern-
ment of Rhineland-Palatinate (“Stiftung RheinlandPfalz für Innovation“, contract AZ 961–386261/733), the research pro- grams “Wissen schafft Zukunft” and “Center for Translational Vascular Biology (CTVB)” of the Johannes Gutenberg- University of Mainz, and its contract with Boehringer Ingelheim and PHILIPS Medical Systems, including unre- stricted grants for the Gutenberg Health Study. This work was supported by the German Federal Ministry of Education and Research (BMBF 01EO1003) and the Center for Translational Vascular Biology (CTVB) of the University Medical Center Mainz (to PSW). HtC is a Fellow of the Gutenberg Research Foundation.
References
1. Spronk HM, Govers-Riemslag JW, ten Cate H. The blood coagulation system as a molecular machine. Bioessays. 2003;25(12): 1220-1228.
2. Dargaud Y, Beguin S, Lienhart A, et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost. 2005;93(3):475- 480.
3. Besser M, Baglin C, Luddington R, van Hylckama Vlieg A, Baglin T. High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generat- ing potential in a prospective cohort study. J Thromb Haemost. 2008;6(10):1720-1725.
4. Loeffen R, van Oerle R, Leers MP, et al . Factor XIa and thrombin generation are elevated in patients with acute coronary syndrome and predict recurrent cardiovas- cular events. PLoS One. 2016;11(7): e0158355.
5. Loeffen R, Winckers K, Ford I, et al. Associations between thrombin generation and the risk of cardiovascular disease in eld- erly patients: results from the PROSPER study. J Gerontol A Biol Sci Med Sci. 2015;70(8):982-988.
6. Lutsey PL, Folsom AR, Heckbert SR, Cushman M. Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thrombo- embolism Etiology (LITE) study. J Thromb Haemost. 2009;7(10):1639-1648.
7. Smid M, Dielis AW, Spronk HM, et al. Thrombin generation in the Glasgow Myocardial Infarction Study. PLoS One. 2013;8(6):e66977.
8. ten Cate-Hoek AJ, Dielis AW, Spronk HM, et al. Thrombin generation in patients after acute deep-vein thrombosis. Thromb Haemost. 2008;100(2):240-245.
9. Hemker HC, Giesen P, AlDieri R, et al. The calibrated automated thrombogram (CAT): a universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb. 2002;32(5-6):249-253.
10. Dielis AW, Castoldi E, Spronk HM, et al. Coagulation factors and the protein C sys- tem as determinants of thrombin generation in a normal population. J Thromb Haemost. 2008;6(1):125-131.
11. Haidl H, Cimenti C, Leschnik B, Zach D,
Muntean W. Age-dependency of thrombin generation measured by means of calibrated automated thrombography (CAT). Thromb Haemost. 2006;95(5):772-775.
12. Chaireti R, Gustafsson KM, Bystrom B, Bremme K, Lindahl TL. Endogenous throm- bin potential is higher during the luteal phase than during the follicular phase of a normal menstrual cycle. Hum Reprod. 2013;28(7):1846-1852.
13. Wild PS, Zeller T, Beutel M, et al. [The Gutenberg Health Study]. Bundesgesundheitsblatt Gesundheitsforschu ng Gesundheitsschutz. 2012;55(6-7):824-829.
14. Schnabel RB, Wilde S, Wild PS, Munzel T, Blankenberg S. Atrial fibrillation: its preva- lence and risk factor profile in the German general population. Dtsch Arztebl Int. 2012;109(16):293-299.
Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mel- litus: influence of type of diabetes, obesity index, and age. Thromb Res. 2001;101(5): 367-375.
22. Beijers HJ, Ferreira I, Spronk HM, et al. Body composition as determinant of thrombin generation in plasma: the Hoorn study. Arterioscler Thromb Vasc Biol. 2010;30(12): 2639-2647.
23. Pruller F, Raggam RB, Posch V, et al. Trunk weighted obesity, cholesterol levels and low grade inflammation are main determinants for enhanced thrombin generation. Atherosclerosis. 2012;220(1):215-218.
24. Brodin E, Seljeflot I, Arnesen H, Hurlen M, Appelbom H, Hansen JB. Endogenous thrombin potential (ETP) in plasma from patients with AMI during antithrombotic treatment. Thromb Res. 2009;123(4):573-
15. Wild PS, Sinning CR, Roth A, et al. Distribution and categorization of left ven- 579.
tricular measurements in the general popu- lation: results from the population-based Gutenberg Heart Study. Circ Cardiovasc Imaging. 2010;3(5):604-613.
16. Loeffen R, Kleinegris MC, Loubele ST, et al. Preanalytic variables of thrombin genera- tion: towards a standard procedure and val- idation of the method. J Thromb Haemost. 2012;10(12):2544-2554.
17. Eikelboom JW, Connolly SJ, Bosch J, et al. Rivaroxaban with or without aspirin in sta- ble cardiovascular disease. N Engl J Med. 2017;377(14):1319-1330.
18. Lowe GD, Rumley A, Woodward M, et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey. I. Illustrative reference ranges by age, sex and hormone use. Br J Haematol. 1997;97(4):775-784.
19. Spronk HM, Dielis AW, De Smedt E, et al. Assessment of thrombin generation II: vali- dation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory. Thromb Haemost. 2008;100(2):362-364.
25. Wielders S, Mukherjee M, Michiels J, et al. The routine determination of the endoge- nous thrombin potential, first results in dif- ferent forms of hyper- and hypocoagulabili- ty. Thromb Haemost. 1997;77(4):629-636.
26. Gatt A, van Veen JJ, Bowyer A, et al. Wide variation in thrombin generation in patients with atrial fibrillation and therapeutic International Normalized Ratio is not due to inflammation. Br J Haematol. 2008;142(6): 946-952.
27. Rotteveel RC, Roozendaal KJ, Eijsman L, Hemker HC. The influence of oral contra- ceptives on the time-integral of thrombin generation (thrombin potential). Thromb Haemost. 1993;70(6):959-962.
28. Tchaikovski SN, van Vliet HA, Thomassen MC, et al. Effect of oral contraceptives on thrombin generation measured via calibrat- ed automated thrombography. Thromb Haemost. 2007;98(6):1350-1356.
29. Marchi R, Marcos L, Paradisi I. Comparison by sex between thrombin generation and fibrin network characteristics in a healthy population. Clin Chim Acta. 2015;441:86-
20. Leurs PB, Stolk RP, Hamulyak K, Van Oerle 89.
R, Grobbee DE, Wolffenbuttel BH. Tissue factor pathway inhibitor and other endothelium-dependent hemostatic fac- tors in elderly individuals with normal or impaired glucose tolerance and type 2 dia- betes. Diabetes Care. 2002;25(8):1340- 1345.
21. Vambergue A, Rugeri L, Gaveriaux V, et al.
30. Attanasio M, Marcucci R, Gori AM, et al. Residual thrombin potential predicts cardio- vascular death in acute coronary syndrome patients undergoing percutaneous coronary intervention. Thromb Res. 2016;147:52-57.
31. James PT, Leach R, Kalamara E, Shayeghi M. The worldwide obesity epidemic. Obes Res. 2001;9(Suppl 4):228S-233S.
2334
haematologica | 2020; 105(9)